Read Time:8 Second
Precision medicine company Tempus AI said its initial public offering of 11.1 million shares priced at $37 each, compared with an estimated range of $35 to $37.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
